General (Internal) Medicine – Publications

GENERAL (INTERNAL) MEDICINE DEPARTMENT – PUBLICATIONS 2018

Nocebos in rheumatology: emerging concepts and their implications for clinical practice.

Kravvariti E, Kitas GD, Mitsikostas DD, Sfikakis PP.

Nat Rev Rheumatol. 2018 Oct 25. doi: 10.1038/s41584-018-0110-9. [Epub ahead of print] Review.

PMID: 30361674

Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study.

Psichogiou M, Kapelios CJ, Konstantonis G, Argyris A, Nasothimiou E, Papadopoulou M, Kitas G, Papaioannou TG, Daikos GL, Sfikakis PP, Protogerou AD.

Angiology. 2018 Sep 20:3319718801093. doi: 10.1177/0003319718801093. [Epub ahead of print]

PMID: 30235944

Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Aug 13. doi: 10.1093/rheumatology/key242. [Epub ahead of print]

PMID: 30107448

Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.

Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG.

Rheumatology (Oxford). 2018 Aug 8. doi: 10.1093/rheumatology/key233. [Epub ahead of print]

PMID: 30102390

Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Poulos G, Kolovou G, Theodorakis G, Kitas GD.

Rheumatol Int. 2018 Sep;38(9):1615-1621. doi: 10.1007/s00296-018-4110-5. Epub 2018 Jul 24. Review.

PMID: 30043238

Management of skin, mucosa and joint involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2018 May 19. pii: S0049-0172(18)30240-3. doi: 10.1016/j.semarthrit.2018.05.008. [Epub ahead of print]

PMID: 29954598

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.

Arida A, Protogerou AD, Kitas GD, Sfikakis PP.

Int J Mol Sci. 2018 Jun 27;19(7). pii: E1890. doi: 10.3390/ijms19071890. Review.

PMID: 29954107

Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort.

Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG.

Autoimmun Rev. 2018 Aug;17(8):816-820. doi: 10.1016/j.autrev.2018.02.008. Epub 2018 Jun 6.

PMID: 29885536

Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.

Eleftheriadou I, Drosos GC, Tentolouris A, George K, Sfikakis PP, Protogerou AD, Tentolouris N.

J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038/s41371-018-0070-1. Epub 2018 May 23.

PMID: 29789692

Microwave Radiometry-Derived Thermal Changes of Small Joints as Additional Potential Biomarker in Rheumatoid Arthritis: A Prospective Pilot Study.

Pentazos G, Laskari K, Prekas K, Raftakis J, Sfikakis PP, Siores E.

J Clin Rheumatol. 2018 Aug;24(5):259-263. doi: 10.1097/RHU.0000000000000719.

PMID: 29652702

2018 update of the EULAR recommendations for the management of Behçet’s syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID: 29625968

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Feb 23. pii: S0049-0172(17)30803-X. doi: 10.1016/j.semarthrit.2018.02.014. [Epub ahead of print]

PMID: 29555348

Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.

Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD.

Rheumatol Int. 2018 Jun;38(6):949-958. doi: 10.1007/s00296-018-4004-6. Epub 2018 Mar 7. Review.

PMID: 29516170

Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease.

Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D.

Echocardiography. 2018 Jun;35(6):804-808. doi: 10.1111/echo.13846. Epub 2018 Feb 28.

PMID: 29490113

Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis.

Dokoupilová E, Aelion J, Takeuchi T, Malavolta N, Sfikakis PP, Wang Y, Rohrer S, Richards HB.

Scand J Rheumatol. 2018 Jul;47(4):276-281. doi: 10.1080/03009742.2017.1390605. Epub 2018 Feb 20.

PMID: 29458278

24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.

Yu S, Chi C, Protogerou AD, Safar ME, Blacher J, Argyris AA, Nasothimiou EG, Sfikakis PP, Papaioannou TG, Xu H, Zhang Y, Xu Y.

J Clin Hypertens (Greenwich). 2018 Mar;20(3):499-507. doi: 10.1111/jch.13226. Epub 2018 Feb 19.

PMID: 29457351

Mechanisms of pulse pressure amplification dipping pattern during sleep time: the SAFAR study.

Argyris AA, Nasothimiou E, Aissopou E, Papaioannou TG, Zhang Y, Blacher J, Safar ME, Sfikakis PP, Protogerou AD.

J Am Soc Hypertens. 2018 Feb;12(2):117-127. doi: 10.1016/j.jash.2017.12.005. Epub 2017 Dec 14.

PMID: 29287945

Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.

Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.

Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.

PMID: 29150207

Non-invasive vascular biomarkers in patients with Behçet’s disease: review of the data and future perspectives.

Protogerou AD, Nasothimiou EG, Sfikakis PP, Tzioufas AG.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):100-107. Epub 2017 Oct 6. Review.

PMID: 29148423

High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.

Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, Sidiropoulos P, Vassilopoulos D.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):254-262. Epub 2017 Nov 9.

PMID: 29148406

The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Papageorgiou SG, Kontos CK, Kotsianidis I, Vasilatou D, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Diamantopoulos MA, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.

Hematol Oncol. 2018 Oct;36(4):693-700. doi: 10.1002/hon.2551. Epub 2018 Sep 7.

PMID: 30129144

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.

Papageorgiou SG, Kotsianidis I, Kontos CK, Symeonidis A, Galanopoulos A, Hatzimichael E, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.

Leuk Res. 2018 Aug;71:55-59. doi: 10.1016/j.leukres.2018.07.004. Epub 2018 Jul 7. No abstract available.

PMID: 30007218

Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis.

Dimou M, Iliakis T, Maltezas D, Bitsani A, Kalyva S, Koudouna A, Kotsanti S, Petsa P, Papaioannou P, Kyrtsonis MC, Panayiotidis P.

Anticancer Res. 2018 Jul;38(7):4187-4191. doi: 10.21873/anticanres.12712.

PMID: 29970548

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.

Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M.

Hematol Oncol. 2018 Oct;36(4):645-650. doi: 10.1002/hon.2521. Epub 2018 Jun 8.

PMID: 29882363

Primary Hepatic Burkitt Lymphoma in a Kidney Transplant Recipient.

Lionaki S, Tsakonas E, Androulaki A, Liapis G, Panayiotidis P, Zavos G, Boletis JN.

Case Rep Nephrol. 2018 May 13;2018:7425785. doi: 10.1155/2018/7425785. eCollection 2018.

PMID: 29862100

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.

Saussele S, Richter J, Guilhot J, Gruber FX, Hjorth-Hansen H, Almeida A, Janssen JJWM, Mayer J, Koskenvesa P, Panayiotidis P, Olsson-Strömberg U, Martinez-Lopez J, Rousselot P, Vestergaard H, Ehrencrona H, Kairisto V, Machová Poláková K, Müller MC, Mustjoki S, Berger MG, Fabarius A, Hofmann WK, Hochhaus A, Pfirrmann M, Mahon FX; EURO-SKI investigators.

Lancet Oncol. 2018 Jun;19(6):747-757. doi: 10.1016/S1470-2045(18)30192-X. Epub 2018 May 4.

PMID: 29735299

The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.

Papageorgiou SG, Vasilatou D, Kontos CK, Kotsianidis I, Symeonidis A, Galanopoulos AG, Hatzimichael E, Megalakaki A, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Mparmparousi D, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.

Am J Hematol. 2018 Jul;93(7):895-901. doi: 10.1002/ajh.25111. Epub 2018 May 16.

PMID: 29659040

Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.

Boutsikas G, Terpos E, Papatheodorou A, Tsirkinidis P, Tsirigotis P, Meletiou A, Lalou E, Telonis V, Zannou A, Kanellopoulos A, Galani Z, Stefanou A, Tsaftaridis P, Viniou NA, Panayiotidis P, Kyrtsonis MC, Meletis J, Vassilakopoulos TP, Angelopoulou MK.

Eur J Haematol. 2018 Feb;100(2):131-139. doi: 10.1111/ejh.12990. Epub 2017 Dec 4.

PMID: 29105864

The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.

Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP.

Anticancer Res. 2017 Oct;37(10):5727-5736.

PMID: 28982893

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.

Dreyling M, Santoro A, Mollica L, Leppä S, Follows GA, Lenz G, Kim WS, Nagler A, Panayiotidis P, Demeter J, Özcan M, Kosinova M, Bouabdallah K, Morschhauser F, Stevens DA, Trevarthen D, Giurescu M, Cupit L, Liu L, Köchert K, Seidel H, Peña C, Yin S, Hiemeyer F, Garcia-Vargas J, Childs BH, Zinzani PL.

J Clin Oncol. 2017 Dec 10;35(35):3898-3905. doi: 10.1200/JCO.2017.75.4648. Epub 2017 Oct 4.

PMID: 28976790

High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine.

Dimou M, Roumelioti M, Dimitrakopoulou A, Bitsani C, Kotsanti S, Petsa P, Papaioannou P, Kyrtsonis MC, Panayiotidis P.

Leuk Lymphoma. 2018 May;59(5):1264-1267. doi: 10.1080/10428194.2017.1375108. Epub 2017 Sep 13. No abstract available.

PMID: 28901815

Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.

Tsirkinidis P, Terpos E, Boutsikas G, Papatheodorou A, Anargyrou K, Lalou E, Dimitrakopoulou A, Kalpadakis C, Konstantopoulos K, Siakantaris M, Panayiotidis P, Pangalis G, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou MK.

J Bone Miner Metab. 2018 Jul;36(4):399-409. doi: 10.1007/s00774-017-0853-4. Epub 2017 Jun 28.

PMID: 28660376

Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.

P Vassilakopoulos T, Levidou G, Milionis V, Hartmann S, Lakiotaki E, Sepsa A, Thymara I, Ntailiani P, Spanou K, K Angelopoulou M, P Siakantaris M, Moschogiannis M, A Pangalis G, Panayiotidis P, Konstantopoulos K, Patsouris E, Hansmann ML, Korkolopoulou P.

Leuk Lymphoma. 2017 Sep;58(9):1-13. doi: 10.1080/10428194.2017.1289520. Epub 2017 Jun 2.

PMID: 28571489

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.

Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P.

Hematol Oncol. 2018 Feb;36(1):174-181. doi: 10.1002/hon.2383. Epub 2017 Feb 20.

PMID: 28219112

Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms.

Daskalakis K, Chatzelis E, Tsoli M, Papadopoulou-Marketou N, Dimitriadis GK, Tsolakis AV, Kaltsas G.

Endocrine. 2018 Oct 2. doi: 10.1007/s12020-018-1773-3. [Epub ahead of print]

PMID: 30280284

Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece.

Giassa Τ, Mamali I, Gaki Ε, Kaltsas G, Kouraklis G, Markou ΚΒ, Karatzas T.

Hormones (Athens). 2018 Sep 28. doi: 10.1007/s42000-018-0057-x. [Epub ahead of print]

PMID: 30267376

Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms.

Baudin E, Hayes A, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudla B, Gorbounova V, Wiedenmann B, Nieveen van Dijkum E, Cwikla J, Falkerby J, Valle JW, Kulke MH, Caplin M.

Neuroendocrinology. 2018 Sep 24. doi: 10.1159/000493980. [Epub ahead of print]

PMID: 30248673

Lung Carcinoids: long-term surgical results and the lack of prognostic value of somatostatin receptors and other novel IHC markers. <br>.

Daskalakis K, Kaltsas G, Öberg K, Tsolakis AV.

Neuroendocrinology. 2018 Sep 23. doi: 10.1159/000493944. [Epub ahead of print]

PMID: 30244255

Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).

Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla J, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R.

Neuroendocrinology. 2018 Aug 28. doi: 10.1159/000493318. [Epub ahead of print]

PMID: 30153658

Gastric Carcinoids.

Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G.

Endocrinol Metab Clin North Am. 2018 Sep;47(3):645-660. doi: 10.1016/j.ecl.2018.04.013. Epub 2018 Jul 11. Review.

PMID: 30098721

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI.

Ann Transl Med. 2018 Jun;6(12):252. doi: 10.21037/atm.2018.06.27. Review.

PMID: 30069454

Effects of visfatin on brown adipose tissue energy regulation using T37i cells.

Dimitriadis GK, Adya R, Tan BK, Jones TA, Menon VS, Ramanjaneya M, Kaltsas G, Miras AD, Randeva HS.

Cytokine. 2018 Jul 27. pii: S1043-4666(18)30299-0. doi: 10.1016/j.cyto.2018.07.013. [Epub ahead of print]

PMID: 30060995

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.

Nasiri-Ansari Ν, Dimitriadis GK, Agrogiannis G, Perrea D, Kostakis ID, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.

Cardiovasc Diabetol. 2018 Jul 26;17(1):106. doi: 10.1186/s12933-018-0749-1.

PMID: 30049285

Bone metabolism in Langerhans cell histiocytosis.

Anastasilakis AD, Tsoli M, Kaltsas G, Makras P.

Endocr Connect. 2018 Jul;7(7):R246-R253. doi: 10.1530/EC-18-0186. Epub 2018 Jul 2. Review.

PMID: 29967185

Advances on systemic treatment for lung neuroendocrine neoplasms.

Tsoukalas N, Baxevanos P, Aravantinou-Fatorou E, Tolia M, Galanopoulos M, Tsapakidis K, Kyrgias G, Toumpanakis C, Kaltsas G.

Ann Transl Med. 2018 Apr;6(8):146. doi: 10.21037/atm.2018.04.03. Review.

PMID: 29862235

Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?

Kanakis GA, Grimelius L, Papaioannou D, Kaltsas G, Tsolakis AV.

Oncotarget. 2018 Apr 27;9(32):22653-22664. doi: 10.18632/oncotarget.25203. eCollection 2018 Apr 27.

PMID: 29854305

The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.

Kyritsi EM, Dimitriadis GK, Angelousi A, Mehta H, Shad A, Mytilinaiou M, Kaltsas G, Randeva HS.

Eur J Clin Invest. 2018 Jul;48(7):e12961. doi: 10.1111/eci.12961. Epub 2018 Jun 13.

PMID: 29845629

Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations.

Robbins HL, Symington M, Mosterman B, Goodby J, Davies L, Dimitriadis GK, Kaltsas G, Randeva HS, Weickert MO.

Nutr Cancer. 2018 Jul;70(5):748-754. doi: 10.1080/01635581.2018.1470650. Epub 2018 May 21.

PMID: 29781720

Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome.

Weickert MO, Kaltsas G, Hörsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, Öberg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH.

Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016/j.clinthera.2018.04.006. Epub 2018 May 1.

PMID: 29724499

Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion.

Dimitriadis GK, Kaur J, Adya R, Miras AD, Mattu HS, Hattersley JG, Kaltsas G, Tan BK, Randeva HS.

Oncotarget. 2018 Mar 30;9(24):16678-16690. doi: 10.18632/oncotarget.24659. eCollection 2018 Mar 30.

PMID: 29682177

Clock genes alterations and endocrine disorders.

Angelousi A, Kassi E, Nasiri-Ansari N, Weickert MO, Randeva H, Kaltsas G.

Eur J Clin Invest. 2018 Jun;48(6):e12927. doi: 10.1111/eci.12927. Epub 2018 Apr 16. Review.

PMID: 29577261

Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis.

Angelousi A, Cohen C, Sosa S, Danilowicz K, Papanastasiou L, Tsoli M, Pal A, Piaditis G, Grossman A, Kaltsas G.

Horm Metab Res. 2018 Apr;50(4):296-302. doi: 10.1055/s-0044-101036. Epub 2018 Feb 19.

PMID: 29458219

Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.

Grozinsky-Glasberg S, Kaltsas G, Kaltsatou M, Lev-Cohain N, Klimov A, Vergadis V, Uri I, Bloom AI, Gross DJ.

Endocrine. 2018 Jun;60(3):499-509. doi: 10.1007/s12020-018-1537-0. Epub 2018 Jan 30.

PMID: 29383678

Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study.

Makrilakis K, Liatis S, Tsiakou A, Stathi C, Papachristoforou E, Perrea D, Katsilambros N, Kontodimopoulos N, Niakas D.

BMC Endocr Disord. 2018 May 29;18(1):32. doi: 10.1186/s12902-018-0261-3.

PMID: 29843700

Follistatins in glucose regulation of healthy and obese subjects.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13572. [Epub ahead of print]

PMID: 30393997

Advancements in improving health-related quality of life in patients living with diabetic foot ulcers.

Tzeravini E, Tentolouris A, Tentolouris N, Jude EB.

Expert Rev Endocrinol Metab. 2018 Oct 29:1-10. doi: 10.1080/17446651.2018.1541403. [Epub ahead of print]

PMID: 30381974

Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

Grigoropoulou P, Tentolouris A, Eleftheriadou I, Tsilingiris D, Vlachopoulos C, Sykara M, Tentolouris N.

Diab Vasc Dis Res. 2018 Oct 17:1479164118805320. doi: 10.1177/1479164118805320. [Epub ahead of print]

PMID: 30328360

Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis.

Karageorgiou V, Papaioannou TG, Bellos I, Alexandraki K, Tentolouris N, Stefanadis C, Chrousos GP, Tousoulis D.

Metabolism. 2018 Oct 12. pii: S0026-0495(18)30212-9. doi: 10.1016/j.metabol.2018.10.002. [Epub ahead of print] Review.

PMID: 30321535

Pain management of chronic wounds: Diabetic ulcers and beyond.

Paschou SA, Stamou M, Vuagnat H, Tentolouris N, Jude E.

Maturitas. 2018 Nov;117:17-21. doi: 10.1016/j.maturitas.2018.08.013. Epub 2018 Sep 5. Review.

PMID: 30314556

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D’Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 1. pii: S0140-6736(18)32261-X. doi: 10.1016/S0140-6736(18)32261-X. [Epub ahead of print]

PMID: 30291013

Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.

Tentolouris A, Eleftheriadou I, Tsilingiris D, Anastasiou IA, Kosta OA, Mourouzis I, Kokkinos A, Pantos C, Katsilambros N, Tentolouris N.

Horm Metab Res. 2018 Nov;50(11):803-810. doi: 10.1055/a-0748-6170. Epub 2018 Oct 4.

PMID: 30286484

Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Liakos A, Lambadiari V, Bargiota A, Kitsios K, Avramidis I, Kotsa K, Gerou S, Boura P, Tentolouris N, Dimitriadis G, Tsapas A.

Diabetes Obes Metab. 2018 Sep 22. doi: 10.1111/dom.13541. [Epub ahead of print]

PMID: 30242948

Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.

Liaskos C, Koliaki C, Alexiadou K, Argyrakopoulou G, Tentolouris N, Diamantis T, Alexandrou A, Katsilambros N, Kokkinos A.

Obes Surg. 2018 Dec;28(12):3997-4005. doi: 10.1007/s11695-018-3454-y.

PMID: 30112599

Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.

Mamakou V, Hackinger S, Zengini E, Tsompanaki E, Marouli E, Serafetinidis I, Prins B, Karabela A, Glezou E, Southam L, Rayner NW, Kuchenbaecker K, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Zeggini E.

BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186/s12888-018-1826-4.

PMID: 30071838

Diabetic Foot Infections: Update on Management.

Nikoloudi M, Eleftheriadou I, Tentolouris A, Kosta OA, Tentolouris N.

Curr Infect Dis Rep. 2018 Aug 1;20(10):40. doi: 10.1007/s11908-018-0645-6. Review.

PMID: 30069605

The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects.

Argyrakopoulou G, Kontrafouri P, Eleftheriadou I, Kokkinos A, Arapostathi C, Kyriaki D, Perrea D, Revenas C, Katsilambros N, Tentolouris N.

Exp Clin Endocrinol Diabetes. 2018 Jun 11. doi: 10.1055/a-0597-8985. [Epub ahead of print]

PMID: 29890542

Schizophrenia and type 2 diabetes mellitus.

Mamakou V, Thanopoulou A, Gonidakis F, Tentolouris N, Kontaxakis V.

Psychiatriki. 2018 Jan-Mar;29(1):64-73. doi: 10.22365/jpsych.2018.291.64. Review.

PMID: 29754122

Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population.

Tentolouris A, Eleftheriadou I, Athanasakis K, Kyriopoulos J, Tsilimigras DI, Grigoropoulou P, Doupis J, Tentolouris N.

Hellenic J Cardiol. 2018 May 3. pii: S1109-9666(18)30038-1. doi: 10.1016/j.hjc.2018.04.008. [Epub ahead of print]

PMID: 29729413

Hypertension in patients with type 2 diabetes mellitus: Targets and management.

Pavlou DI, Paschou SA, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G.

Maturitas. 2018 Jun;112:71-77. doi: 10.1016/j.maturitas.2018.03.013. Epub 2018 Mar 30. Review.

PMID: 29704920

Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.

Tentolouris A, Eleftheriadou I, Tentolouris N.

Ann Transl Med. 2018 Feb;6(3):63. doi: 10.21037/atm.2017.12.28. No abstract available.

PMID: 29610753

Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.

Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N.

J Int Med Res. 2018 May;46(5):1779-1790. doi: 10.1177/0300060518756540. Epub 2018 Mar 8.

PMID: 29517942

Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity.

Tsiompanidis E, Siakavellas SI, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A, Oikonomou K, Tentolouris N.

World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):28-36. doi: 10.4291/wjgp.v9.i1.28.

PMID: 29487764

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.

Billings LK, Doshi A, Gouet D, Oviedo A, Rodbard HW, Tentolouris N, Grøn R, Halladin N, Jodar E.

Diabetes Care. 2018 May;41(5):1009-1016. doi: 10.2337/dc17-1114. Epub 2018 Feb 26.

PMID: 29483185

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.

Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J.

Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007/s10741-018-9674-3. Review.

PMID: 29383638

Associations between adiponectin gene variability, pro-inflammatory and angiogenetic markers: implications for microvascular disease development in type 2 diabetes mellitus?

Kollia C, Antonopoulos AS, Siasos G, Konsola T, Oikonomou E, Gouliopoulos N, Tsigkou V, Papapanagiotou A, Kassi E, Tentolouris N, Katsiki N, Vavuranakis M, Papavassiliou AG, Tousoulis D.

Curr Vasc Pharmacol. 2018 Jan 7. doi: 10.2174/1570161116666180108113825. [Epub ahead of print]

PMID: 29308741

A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the Feel4Diabetes-study.

Manios Y, Androutsos O, Lambrinou CP, Cardon G, Lindstrom J, Annemans L, Mateo-Gallego R, de Sabata MS, Iotova V, Kivela J, Martinez R, Moreno LA, Rurik I, Schwarz P, Tankova T, Liatis S, Makrilakis K.

Public Health Nutr. 2018 Sep 12:1-10. doi: 10.1017/S1368980018002136. [Epub ahead of print]

PMID: 30207513

Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic Review.

Owolabi MO, Yaria JO, Daivadanam M, Makanjuola AI, Parker G, Oldenburg B, Vedanthan R, Norris S, Oguntoye AR, Osundina MA, Herasme O, Lakoh S, Ogunjimi LO, Abraham SE, Olowoyo P, Jenkins C, Feng W, Bayona H, Mohan S, Joshi R, Webster R, Kengne AP, Trofor A, Lotrean LM, Praveen D, Zafra-Tanaka JH, Lazo-Porras M, Bobrow K, Riddell MA, Makrilakis K, Manios Y, Ovbiagele B; COUNCIL Initiative.

Diabetes Care. 2018 May;41(5):1097-1105. doi: 10.2337/dc17-1795. Review.

PMID: 29678866

Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.

Makrilakis K, Liatis S.

J Diabetes Res. 2017;2017:8927473. doi: 10.1155/2017/8927473. Epub 2017 Dec 14. Review.

PMID: 29387731

Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.

Mamakou V, Eleftheriadou I, Katsiki N, Makrilakis K, Tsioufis K, Tentolouris N.

Curr Vasc Pharmacol. 2017;16(1):70-78. doi: 10.2174/1570161115666171010122332. Review.

PMID: 29032756

Hypoglycaemia causes both daytime and nighttime QTc interval prolongation in patients with type 2 diabetes receiving insulin treatment.

Makrilakis K, Stathi C, Vlahodimitris I, Kalopita S, Thomakos P, Konstantopoulos P, Perrea D, Katsilambros N, Liatis S.

Diabetes Metab. 2018 Mar;44(2):175-177. doi: 10.1016/j.diabet.2017.08.005. Epub 2017 Oct 10. No abstract available.

PMID: 29029946

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E.

Ann Hematol. 2018 Sep;97(9):1747. doi: 10.1007/s00277-018-3404-8.

PMID: 29943159

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.

Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP.

Blood. 2018 Aug 9;132(6):666-670. doi: 10.1182/blood-2018-02-833608. Epub 2018 Jun 18. No abstract available.

PMID: 29914978

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia.

Dimopoulos MA, Tedeschi A, Trotman J, García-Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C; iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia.

N Engl J Med. 2018 Jun 21;378(25):2399-2410. doi: 10.1056/NEJMoa1802917. Epub 2018 Jun 1.

PMID: 29856685

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.

Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E.

Ann Hematol. 2018 Sep;97(9):1671-1682. doi: 10.1007/s00277-018-3361-2. Epub 2018 May 13. Erratum in: Ann Hematol. 2018 Jun 26;:.

PMID: 29756171

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.

Katodritou E, Terpos E, Delimpasi S, Kotsopoulou M, Michalis E, Vadikolia C, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Vadikolia C, Michael M, Kalpadakis C, Gougopoulou T, Prokopiou C, Kaiafa G, Christoulas D, Gavriatopoulou M, Giannopoulou E, Labropoulou V, Verrou E, Kastritis E, Konstantinidou P, Anagnostopoulos A, Dimopoulos MA.

Blood Cancer J. 2018 Mar 9;8(3):31. doi: 10.1038/s41408-018-0059-6.

PMID: 29523783

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.

Zagouri F, Kastritis E, Zomas A, Terpos E, Katodritou E, Symeonidis A, Delimpasi S, Pouli A, Vassilakopoulos TP, Michalis E, Giannouli S, Kartasis Z, Christoforidou A, Kokoviadou K, Hatzimichael E, Gika D, Megalakaki C, Papaioannou M, Kyrtsonis MC, Konstantopoulos K, Dimopoulos MA; Greek Myeloma Study Group.

Eur J Haematol. 2017 Nov;99(5):409-414. doi: 10.1111/ejh.12923. Epub 2017 Sep 26.

PMID: 28675766

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2018 Sep 17. doi: 10.1111/1471-0528.15469. [Epub ahead of print]

PMID: 30222236

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2018 Aug 25. doi: 10.1007/s10067-018-4267-z. [Epub ahead of print]

PMID: 30145635

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.

Tektonidou MG.

Front Immunol. 2018 May 31;9:1181. doi: 10.3389/fimmu.2018.01181. eCollection 2018. Review.

PMID: 29904380

B-cell activating factor and related genetic variants in lupus related atherosclerosis.

Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M, Moutsopoulos HM, Mavragani CP.

J Autoimmun. 2018 Aug;92:87-92. doi: 10.1016/j.jaut.2018.05.002. Epub 2018 May 31.

PMID: 29859654

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody Positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository.

Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; TheBehalf of APS ACTION.

Arthritis Care Res (Hoboken). 2018 Apr 18. doi: 10.1002/acr.23584. [Epub ahead of print]

PMID: 29669399

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients.

Rodríguez-Pintó I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R; CAPS Registry Project Group .

Rheumatology (Oxford). 2018 Apr 11. doi: 10.1093/rheumatology/key082. [Epub ahead of print]

PMID: 29660074

Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.

Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking.

Blood Adv. 2017 Nov 16;1(25):2320-2324. doi: 10.1182/bloodadvances.2017008185. eCollection 2017 Nov 28.

PMID: 29296881

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.

Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E, Katsifis G, Vartela V, Kolovou G.

Lupus. 2018 Apr;27(4):564-571. doi: 10.1177/0961203317731533. Epub 2017 Sep 19.

PMID: 28927316

Brief Report: Drug-Free Long-Term Remission in Severe Behçet’s Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.

Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N.

Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002/art.40235. Epub 2017 Nov 8.

PMID: 28834393

Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016.

Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM.

Ann Rheum Dis. 2017 Dec;76(12):2009-2016. doi: 10.1136/annrheumdis-2017-211663. Epub 2017 Aug 9. Review. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472.

PMID: 28794077

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.

Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E, Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS ACTION.

Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.

PMID: 28764618

Obesity and cardiovascular disease: revisiting an old relationship.

Koliaki C, Liatis S, Kokkinos A.

Metabolism. 2018 Nov 3. pii: S0026-0495(18)30229-4. doi: 10.1016/j.metabol.2018.10.011. [Epub ahead of print] Review.

PMID: 30399375

Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.

Comment on: Adiponectin gene variant RS rs266729: Relation to lipid profile changes and circulating adiponectin after bariatric surgery.

Koliaki C, Kokkinos A.

Surg Obes Relat Dis. 2018 Sep;14(9):1408-1410. doi: 10.1016/j.soard.2018.06.025. Epub 2018 Jul 1. No abstract available.

PMID: 30061069

Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease.

Asprouli E, Kalafati I, Sakellari A, Karavoltsos S, Vlachogiannakos J, Revenas K, Kokkinos A, Dassenakis M, Dedoussis GV, Kalogeropoulos N.

Biol Trace Elem Res. 2018 Jul 16. doi: 10.1007/s12011-018-1432-9. [Epub ahead of print]

PMID: 30014284

Dietary patterns in NAFLD and their interaction with polymorphisms in PNPLA3 and TM6SF2 genes.

Borsa D, Kalafati IP, Vlachogiannakos J, Revenas K, Kokkinos A, Ladas S, Dedoussis G.

Clin Nutr ESPEN. 2018 Apr;24:182. doi: 10.1016/j.clnesp.2018.01.041. Epub 2018 Mar 22. No abstract available.

PMID: 29616948

Adherence to the Mediterranean diet and metabolic parameters in patients with chronic kidney disease stage 5.

Papageorgiou O, Poulia KA, Skalioti CN, Melexopoulou C, Kokkinos A, Perrea D, Boletis IN.

Clin Nutr ESPEN. 2018 Apr;24:176. doi: 10.1016/j.clnesp.2018.01.020. Epub 2018 Mar 22. No abstract available.

PMID: 29616930

Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study.

Kalafati IP, Dimitriou M, Borsa D, Vlachogiannakos J, Revenas K, Kokkinos A, Ladas SD, Dedoussis GV.

Eur J Nutr. 2018 Mar 24. doi: 10.1007/s00394-018-1675-4. [Epub ahead of print]

PMID: 29574608

The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.

Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N.

J Diabetes Complications. 2017 Nov;31(11):1624-1629. doi: 10.1016/j.jdiacomp.2017.07.010. Epub 2017 Jul 27.

PMID: 28893495

The role of bariatric surgery to treat diabetes: current challenges and perspectives.

Koliaki C, Liatis S, le Roux CW, Kokkinos A.

BMC Endocr Disord. 2017 Aug 10;17(1):50. doi: 10.1186/s12902-017-0202-6. Review.

PMID: 28797248

A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326.

Kaliora AC, Kalafati IP, Gioxari A, Diolintzi A, Kokkinos A, Dedoussis GV.

Eur J Nutr. 2018 Sep;57(6):2227-2235. doi: 10.1007/s00394-017-1499-7. Epub 2017 Jul 10.

PMID: 28695325

Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications.

Eleftheriadou I, Grigoropoulou P, Liberopoulos E, Liatis S, Kokkinos A, Tentolouris N.

Curr Med Chem. 2018;25(13):1549-1566. doi: 10.2174/0929867324666170530075533.

PMID: 28554326

Prostatic abscess in a patient with chronic granulomatous disease: a multi-disciplinary intervention.

Martini A, Katafigiotis I, Kalantzi S, Anastasiou I, Adamakis I, Toskas A, Constantinides CA.

Urologia. 2017 Feb 8:0. doi: 10.5301/uro.5000216. [Epub ahead of print]

PMID: 28218357

Clinical pharmacology of glucagon-like peptide-1 receptor agonists.

Sfairopoulos D, Liatis S, Tigas S, Liberopoulos E.

Hormones (Athens). 2018 Sep;17(3):333-350. doi: 10.1007/s42000-018-0038-0. Epub 2018 Jun 12. Review.

PMID: 29949126

Thermal heterogeneity of carotid arteries as a novel biomarker in patients with diabetes mellitus assessed for coronary artery disease.

Tzanis G, Bonou M, Benetos G, Biliou S, Liatis S, Kapelios C, Toutouzas K, Tousoulis D, Barbetseas J.

Int J Cardiol. 2018 Jul 1;262:20-24. doi: 10.1016/j.ijcard.2018.03.102. Epub 2018 Mar 29.

PMID: 29605471

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

PMID: 28854085

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.

N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.

PMID: 28605603

Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.

Durojaiye OC, Cartwright K, Ntziora F.

Diagn Microbiol Infect Dis. 2018 Jul 24. pii: S0732-8893(18)30249-9. doi: 10.1016/j.diagmicrobio.2018.07.013. [Epub ahead of print]

PMID: 30098851

Syphilis infection in an HIV patient presenting with leukemoid reaction: Case report and review of the literature.

Lioni A, Zorzou MP, Kollia C, Loulakis D, Ntziora F, Stergiou F, Boboli M, Chini M.

Infect Dis Rep. 2018 Mar 29;10(1):7410. doi: 10.4081/idr.2018.7410. eCollection 2018 Mar 29.

PMID: 29721241

Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.

Durojaiye OC, Bell H, Andrews D, Ntziora F, Cartwright K.

Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30.

PMID: 28673610